FDA-EMA-TGA Joint Inspection Program To Be Permanent; Other Collaborations Expand

FDA, the European Medicines Agency and Australian Therapeutic Goods Administration intend to make permanent a pilot program allowing for joint facility inspections in what would be another step toward more U.S. reliance on foreign regulator and third-party data and a reduction in inspection burden.